AA amyloidosis associated with macroglobulinemia

被引：4
|
作者：
Tatara, Raine [1 ]
Nagai, Tadashi [1 ]
Kobayashi, Hiroyuki [1 ]
Hatano, Kaoru [1 ]
Suzuki, Takahiro [1 ]
Muroi, Kazuo [2 ]
Ozawa, Keiya [1 ]
机构：
[1] Jichi Med Univ, Div Hematol, Shimotsuke, Tochigi 3290498, Japan
[2] Jichi Med Univ, Div Cell Transplantat & Transfus, Shimotsuke, Tochigi 3290498, Japan
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2010年 / 92卷 / 04期
关键词：
SECONDARY;
D O I：
10.1007/s12185-010-0700-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：675 / 677
页数：3
相关论文
共 50 条
  • [21] Recovery from AA amyloidosis-cardiomyopathy complexed with unicentric Castleman disease
    Imamura, Kanako
    Kojima, Sunao
    Imamura, Takahisa
    Tsujita, Kenichi
    BMJ CASE REPORTS, 2022, 15 (08)
  • [22] Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis
    Kluve-Beckerman, Barbara
    Hardwick, Joyce
    Du, Lijing
    Benson, Merrill D.
    Monia, Brett P.
    Watt, Andrew
    Crooke, Rosanne M.
    Mullick, Adam
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 (03): : 136 - 146
  • [23] Predicting genetic risk factors for AA amyloidosis in Algerian patients with familial Mediterranean fever
    Ait-Idir, Djouher
    Djerdjouri, Bahia
    Latreche, Khaled
    Sari-Hamidou, Rawda
    Khellaf, Ghalia
    MOLECULAR GENETICS AND GENOMICS, 2024, 299 (01)
  • [24] Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents
    Wada, Y.
    Kobayashi, D.
    Murakami, S.
    Oda, M.
    Hanawa, H.
    Kuroda, T.
    Nakano, M.
    Narita, I.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2011, 40 (05) : 402 - 404
  • [25] Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
    Yamada, Yumi
    Ueno, Toshinori
    Irifuku, Taisuke
    Nakashima, Ayumu
    Doi, Shigehiro
    Ichinohe, Tatsuo
    Masaki, Takao
    CLINICAL NEPHROLOGY, 2018, 90 (03) : 232 - 236
  • [26] Use of Biologic Therapy in AA Amyloidosis Patients Undergoing Dialysis-A Systematic Literature Review
    Torun, Ege Sinan
    Kadioglu, Guelay
    HEMODIALYSIS INTERNATIONAL, 2025,
  • [27] Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey
    Bektas, Murat
    Koca, Nevzat
    Oguz, Emin
    Sari, Selma
    Dagci, Gizem
    Ince, Burak
    Ozer, Pelin Karaca
    Agargun, Besim Fazil
    Yalcinkaya, Yasemin
    Artim-Esen, Bahar
    Ocal, Lale
    Inanc, Murat
    Gul, Ahmet
    RHEUMATOLOGY, 2024, 63 (02) : 319 - 328
  • [28] Epidermolysis Bullosa Complicated with Nephrotic Syndrome Due to AA Amyloidosis: A Case Report and Brief Review of Literature
    Pinarbasi, Ayse Seda
    Dursun, Ismail
    Daldaban, Burcu
    Gunay, Neslihan
    Cicek, Sumeyra
    Sahin, Nihal
    Yel, Sibel
    Poyrazoglu, Muammer Hakan
    Akgun, Hulya
    Dusunsel, Ruhan
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2019, 30 (06) : 1450 - 1456
  • [29] Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases
    Okuda, Yasuaki
    Ohnishi, Makoto
    Matoba, Kenichiro
    Jouyama, Kazuo
    Yamada, Akihiro
    Sawada, Naoya
    Mokuda, Sho
    Murata, Yousuke
    Takasugi, Kiyoshi
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 137 - 143
  • [30] Successful treatment of AA amyloidosis with tocilizumab, resulting in the disappearance of amyloid deposits: a case-based review
    Tortosa-Cabanas, Marina
    Batlle, Jose Acosta
    Perna, Cristian
    Bachiller-Corral, Javier
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2024, 51 (01)
12345